Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

New combination meningitis/hepatitis vaccine approved

Oct. 11, 1996

Fujisawa pursues new indications for tacrolimus

Oct. 11, 1996

Successful reversal of acute kidney graft rejection with Thymoglobulin

Oct. 11, 1996

BioTransplant's transplant technologies covered by four new patents

Oct. 11, 1996

Evidence indicates wider application of VasoCare therapy

Oct. 11, 1996

Cytel-Baxter xenotransplantation collaboration

Oct. 11, 1996

First recombinant DTaP vaccine submitted for FDA approval

Oct. 11, 1996

SangStat's ciclosporin bioequivalent to Sandoz drug

Oct. 11, 1996

Cel-Sci forms collaboration for development of herpesvirus vaccine

Oct. 11, 1996

Protein Design Labs' humanized antibody effective in reducing kidney transplant rejection

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.